Labajo, Erbien G.
HRN: 23-60-66 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/15/2023
09/21/2023
IVT
60mg
Od
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes